The ReadoutNocion gets hit with a lawsuit & Aimmune’s adcom gets underway By Adam Feuerstein Sept. 13, 2019 Reprints Alex Hogan/STAT The Readout for September 13, 2019 About the Author Reprints Adam Feuerstein Senior Writer, Biotech Adam Feuerstein is STAT’s national biotech columnist, reporting on the intersection of biotech and Wall Street. He's also a co-host of "The Readout LOUD" podcast. [email protected] @adamfeuerstein
The Readout Meghana Keshavan Regeneron targets obesity, a new microbiome deal, & comparing cancer drug costs
The Readout Damian Garde Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries & regenerating heart tissue
Pharmalot Ed Silverman and Damian Garde STAT Plus: Shortage of monkeys for early-stage research jeopardizes timelines for developing some drugs
Special Report Brittany Trang STAT Plus: As AI promises to revolutionize medical note-taking, concerns mount about accuracy and harm
A STAT Investigation Casey Ross and Bob Herman STAT Plus: Denied by AI: How Medicare Advantage plans use algorithms to cut off care for seniors in need
